IntelGenx Technologies Corp. Stock OTC Bulletin Board
Equities
IGX
US45822R1014
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
Sales 2022 | 950K 1.3M | Sales 2023 | 1.04M 1.42M | Capitalization | 24.12M 32.9M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.64M | Net income 2023 | -9M -12.27M | EV / Sales 2022 | 44.7 x |
Net Debt 2022 | 7.98M 10.89M | Net Debt 2023 | 13.22M 18.03M | EV / Sales 2023 | 35.9 x |
P/E ratio 2022 |
-2.82
x | P/E ratio 2023 |
-2.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.6% |
Latest transcript on IntelGenx Technologies Corp.
Managers | Title | Age | Since |
---|---|---|---|
Dwight Gorham
CEO | Chief Executive Officer | 66 | 23-04-12 |
André Godin
DFI | Director of Finance/CFO | 61 | 15-07-19 |
Horst Zerbe
CHM | Chairman | 77 | 06-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Horst Zerbe
CHM | Chairman | 77 | 06-03-31 |
Mark Nawacki
BRD | Director/Board Member | 54 | 16-08-08 |
Bernd Melchers
BRD | Director/Board Member | 72 | 09-04-07 |
1st Jan change | Capi. | |
---|---|---|
+20.44% | 21.89B | |
+13.90% | 14.45B | |
+13.15% | 13.63B | |
+37.62% | 11.49B | |
-8.59% | 6.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.35% | 5.06B | |
-5.36% | 4.66B |
- Stock Market
- Equities
- IGXT Stock
- IGX Stock